Named as a key player in 99 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Oncology/Cancer Drugs | Pharmaceuticals | $177 Bn | 8.4% |
| HIV Drugs | Pharmaceuticals | $30 Bn | 5.8% |
| Cell Based Immunotherapy | Pharmaceuticals | $16.6 Bn | 23% |
Named as key players in the same markets as Bristol-Myers Squibb (number of shared markets).
AbbVie Inc.2 shared markets
Gilead Sciences, Inc.2 shared markets
Johnson & Johnson2 shared markets
Merck & Co., Inc.2 shared markets
Novartis AG2 shared markets
AstraZeneca1 shared market
Dendreon Pharmaceuticals LLC1 shared market
F. Hoffmann-La Roche Ltd1 shared market